Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ABVC BioPharma Inc | ABVC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.09 | 04:04:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.09 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.6739 - 9.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 1.09 | USD |
ABVC BioPharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.51M | 10.56M | - | 152k | -10.52M | -1.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ABVC BioPharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABVC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.24 | 1.28 | 1.05 | 1.14 | 853,365 | -0.15 | -12.10% |
| 1 Month | 1.15 | 1.45 | 1.03 | 1.26 | 1,872,612 | -0.06 | -5.22% |
| 3 Months | 1.25 | 1.54 | 1.03 | 1.27 | 739,703 | -0.16 | -12.80% |
| 6 Months | 0.94 | 3.35 | 0.82 | 1.53 | 2,457,440 | 0.15 | 15.96% |
| 1 Year | 6.18 | 9.60 | 0.6739 | 2.00 | 1,458,737 | -5.09 | -82.36% |
| 3 Years | 33.20 | 116.883 | 0.6739 | 18.42 | 1,001,578 | -32.11 | -96.72% |
| 5 Years | 33.20 | 116.883 | 0.6739 | 18.42 | 1,001,578 | -32.11 | -96.72% |
ABVC BioPharma Description
| ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes that represent enormous commercial potential. |
